# Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity

> **NCT03903653** · PHASE2 · WITHDRAWN · sponsor: **Hamilton Health Sciences Corporation**

## Conditions studied

- Spastic Foot

## Interventions

- **DRUG:** Botulinum toxin type A
- **DEVICE:** Serial Casting

## Key facts

- **NCT ID:** NCT03903653
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-01
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to enroll patients due to closure of our inpatient units secondary to COVID-19.
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903653, "Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03903653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*